South Africa's Aspen Pharmacare aims to ramp up its Covid-19 vaccine manufacturing capacity to 1.3 billion doses per year by February 2024, from 250 to 300 million doses...
Mylan has agreed to buy the related intellectual property and commercialization rights of Aspen Pharmacare’s European thrombosis business for €641.9 million. The company...
15.09.2017
- AstraZeneca has agreed to sell the remaining rights to its anesthetic drugs portfolio to Aspen Global Incorporated (AGI) in a deal worth up to $766 million. The portfolio comprises...
18.05.2017
- The European Commission (EC) is investigating South African pharmaceutical producer Aspen Pharmacare on charges it raised the price of five cancer drugs by “several hundred per...
28.06.2016
- BASF and Aspen Aerogels have expanded their six-year old collaboration with the signing of two agreements designed to increase market penetration, enhance product profitability and...
15.08.2012
- GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare for 172 million...
